Original story featured in Genomeweb.

Ubiquitome said on Tuesday that the New Zealand Health Research Council and Health Ministry is funding research that pairs the company's handheld PCR device and Oxford Nanopore's Flongle sequencer, which can be used for viral genotyping.

The NZ$165,000 (US$98,141) grant will fund Massey University researchers aiming to enable one person to screen more than 500 samples and obtain 24 whole genome sequences per day. The research is also validating minimal-extraction and extractionless methods, such as heat treatments, for RNA sample preparation to address the shortage of reagents for SARS-CoV-2 tests.

In the short term, the Liberty16 will be used to disperse screening for SARS-CoV-2 detection, and additional data from the viral genotyping will "support more efficient tracking and tracing of disease contacts," a spokesperson from Ubiquitome said. The data collected will also contribute to longer-term research into disease epidemiology, the spokesperson added.

Ubiquitome's Liberty16 device is a handheld, battery-powered real-time PCR device that can test and relay sample data through an iPhone application. The device is commercialized for research use only in Japan, the US, Canada, the United Kingdom, and Germany. The company also previously said it intends to apply for Emergency Use Authorization in the US.

"What we can do is narrow the time between infection, diagnosis, and source and contact tracing," said Ubiquitome's Chief Scientific Officer Susan Turner. "To achieve this we need technologies that enable widespread access to affordable, line-of-sight diagnostic testing, rapid turnaround of results, and efficient methods to track and trace viral transmission."

You may also like

​Ubiquitome’s Liberty16 Attracts Swiss Giant
​Ubiquitome’s Liberty16 Attracts Swiss Giant
19 May, 2020

Ubiquitome has signed an exclusive agreement for Swiss headquartered DKSH to market and sell its mobile, battery powered...

Firmware Update: 1.7.4
Firmware Update: 1.7.4
6 September, 2021

The Liberty16 App has a new security feature! As a part of the new firmware version 1.7.4, the Liberty16 app will now co...

Ubiquitome’s Liberty16 Pro ready to carve up next COVID wave
Ubiquitome’s Liberty16 Pro ready to carve up next COVID wave
27 July, 2022

Faster mobile PCR test device helping business continuity Chicago, July 27, 2022: Ubiquitome , which won through the Uni...